Chemomab Therapeutics (CMMB) Selling, General & Administrative (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | 881,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | 884,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Mar 31, 2025 | 994,000.00 |
| Dec 31, 2024 | 802,000.00 |
| Sep 30, 2024 | 874,000.00 |
| Jun 30, 2024 | 840,000.00 |
| Mar 31, 2024 | 896,000.00 |
| Dec 31, 2023 | 751,000.00 |
| Sep 30, 2023 | 990,000.00 |
| Jun 30, 2023 | 3.18 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 3.34 Mn |
| Mar 31, 2022 | 2.58 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.45 Mn |
| Mar 31, 2021 | 542,000.00 |
| Dec 31, 2020 | 688,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | 254,000.00 |
| Mar 31, 2020 | 152,000.00 |
| Dec 31, 2019 | 1.29 Mn |
| Sep 30, 2019 | 1.71 Mn |
| Jun 30, 2019 | 1.96 Mn |
| Mar 31, 2019 | 1.29 Mn |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 1.13 Mn |
| Jun 30, 2018 | 2.29 Mn |
| Mar 31, 2018 | 926,000.00 |
| Dec 31, 2017 | 875,000.00 |